$2.27
-0.08-3.60%
At Close: -
$2.40
0.135.49%
After Hours: Jul 5, 7:42 AM EDT
15 minutes delayed
Salarius Pharmaceuticals
SLRXNASDAQ
Salarius Pharmaceuticals (NASDAQ:SLRX) Stock, Earnings Estimates, EPS, And Revenue
Salarius Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS Estimate
$-53.600
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Salarius Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SLRX | Salarius Pharmaceuticals | -$11.44 | -$53.60 | — | — | $0.00 | — | — | — | 08/08/2024 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$17.84 | -$53.60 | -$3.28 | 93.88% | $0.00 | — | $0.00 | — | 05/13/2024 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$22.64 | -$8.08 | -$1.76 | 78.22% | $0.00 | — | $0.00 | — | 03/22/2024 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$19.76 | -$9.60 | -$5.20 | 45.83% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$18.00 | -$10.40 | -$11.44 | -10.00% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$26.40 | -$20.72 | -$17.84 | 13.90% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$18.16 | -$17.20 | -$22.64 | -31.63% | $0.00 | — | $0.00 | — | 03/27/2023 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$16.72 | -$20.40 | -$19.76 | 3.14% | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$14.00 | -$20.00 | -$18.00 | 10.00% | $571.39K | — | $0.00 | — | 08/05/2022 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$12.00 | -$18.00 | -$26.00 | -44.44% | $1.27M | — | $0.00 | — | 05/12/2022 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$20.00 | -$16.00 | -$18.00 | -12.50% | $1.48M | $430.00K | $0.00 | -100.00% | 03/10/2022 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$20.00 | -$12.00 | -$16.00 | -33.33% | $1.38M | $1.16M | $0.00 | -100.00% | 11/04/2021 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$26.00 | -$12.00 | -$14.00 | -16.67% | $1.24M | $1.28M | $571.39K | -55.36% | 08/05/2021 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$44.00 | -$10.00 | -$12.00 | -20.00% | $1.13M | $1.37M | $1.27M | -7.37% | 05/12/2021 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$88.00 | -$22.00 | -$20.00 | 9.09% | $1.04M | $1.48M | $1.48M | -0.07% | 03/18/2021 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$146.00 | -$20.00 | -$20.00 | 0.00% | $874.95K | $1.34M | $1.38M | 2.84% | 11/11/2020 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$400.00 | — | -$26.00 | — | $164.71K | $1.19M | $1.24M | 4.45% | 08/12/2020 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$24.00 | — | -$44.00 | — | $105.00K | $5.52M | $1.13M | -79.47% | 05/14/2020 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$22.00 | — | -$88.00 | — | $163.00K | — | $1.04M | — | 03/23/2020 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$30.00 | — | -$146.00 | — | $469.05M | — | $874.95K | — | 11/13/2019 | Get Alert |
| SLRX | Salarius Pharmaceuticals | -$100.00 | — | -$400.00 | — | $246.00K | $251.00K | $164.71K | -34.38% | 07/17/2019 | Get Alert |
Salarius Pharmaceuticals (SLRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-13 | $-3.28 | $-53.60 | 93.9 % |
| Dec 2023 | 2024-03-22 | $-1.76 | $-8.08 | 78.2 % |
| Sep 2023 | 2023-11-09 | $-5.20 | $-9.60 | 45.8 % |
| Jun 2023 | 2023-08-10 | $-11.44 | $-10.40 | -10.0 % |
Salarius Pharmaceuticals (SLRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2021 | 2022-03-10 | $0 | $430.00K | -100.0 % |
| Sep 2021 | 2021-11-04 | $0 | $1.16M | -100.0 % |
| Jun 2021 | 2021-08-05 | $571.39K | $1.28M | -55.4 % |
| Mar 2021 | 2021-05-12 | $1.27M | $1.37M | -7.37 % |
FAQ
When is Salarius Pharmaceuticals (NASDAQ:SLRX) reporting earnings?
Salarius Pharmaceuticals (SLRX) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 13, 2024 for Q1.
What were the latest earnings per share (EPS) for Salarius Pharmaceuticals (NASDAQ:SLRX)?
The Actual EPS was $-3.28, which beat the estimate of $-53.60.
What were Salarius Pharmaceuticals’s (NASDAQ:SLRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.